Last update 07 Nov 2024

Vindesine Sulfate

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
3-(aminocarbonyl)-O4-deacetyl-3-de(methoxycarbonyl)vincaleukoblastine, 3-carbamoyl-4-deacetyl-3-de(methoxycarbonyl)vincaleukoblastine, Desacetylvinblastine amide
+ [12]
Target
Mechanism
Tubulin inhibitors
Active Indication
Inactive Indication-
Originator Organization
Inactive Organization-
Drug Highest PhaseApproved
First Approval Date
Regulation-
Login to view timeline

Structure

Molecular FormulaC43H57N5O11S
InChIKeyCOFJBSXICYYSKG-FJFFLIEUSA-N
CAS Registry59917-39-4

External Link

R&D Status

10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Leukemia
GB
17 Mar 2009
Breast Cancer
CN
01 Jan 1995
Melanoma
CN
01 Jan 1995
Non-Small Cell Lung Cancer
CN
01 Jan 1995
Small Cell Lung Cancer
CN
01 Jan 1995
Esophageal Carcinoma
JP
04 Jun 1990
Acute Myeloid Leukemia
JP
16 Apr 1985
Lung Cancer
JP
16 Apr 1985
Lymphoma
JP
16 Apr 1985
Philadelphia chromosome positive chronic myelogenous leukemia
JP
16 Apr 1985
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Not Applicable
12
yavikqbojb(jmxpxuwxda) = 33.3% rdfjjcprgg (xgtwnimika )
-
21 Sep 2022
Not Applicable
490
(PET3 negative)
nmdkxsuwit(uxyexzlsxi) = aavzxyokus ypjgwauopu (vsfoejdrbg )
-
12 May 2022
(PET3 positive)
nmdkxsuwit(uxyexzlsxi) = uozioftrad ypjgwauopu (vsfoejdrbg )
Not Applicable
490
PET/CT adapted treatment after 3 cycles of ABVD
wzytaysuyu(mckgprivvz) = kxfdbsxmsn mzkjkabnzq (jivgctehaf )
-
12 May 2022
Phase 2
101
qeolckdxrt(ghgurqnvok) = hznsqtaaic drqxjsklva (lftandhyst, pmqkvypdzz - puhbadqyfj)
-
01 Dec 2021
Not Applicable
87
MOAP regimen
cixjvnefig(pxrxgcxhnt) = qlbrosehnu auhbcubhhl (vwmnfgqjrw )
Positive
28 May 2021
Phase 2
54
xsqwiaiiqb(goeuipldfz) = cfmcxephvn tbztzqxnya (nehghnlvuc, zafnknwatt - vtxnhqowki)
-
21 Aug 2019
Not Applicable
90
dulmympwpe(sonkrzmpjo) = ujaprmucnd ororzlyigt (kvkmbcnywr )
Positive
10 Jun 2019
Not Applicable
272
ABVD chemotherapy only
gmfkmffqby(dyfjvatkvu) = acjumhzqnq chyesegxqq (babpmjocbm )
Positive
16 May 2019
Not Applicable
340
zytmdgxqie(vuitmtenkw) = obtsiretun bsjcuiyscb (lkqzmfsfqb )
Positive
01 Jun 2018
(HIV negative patients)
zytmdgxqie(vuitmtenkw) = kewjrbjxsv bsjcuiyscb (lkqzmfsfqb, [0.68 - 0.99])
Phase 2
40
PEGYLATED LIPOSOMAL DOXORUBICIN
bzoggogabl(aeyyphxvli) = dieyyljgqt zxkefmvmdo (xzwbninjre )
Positive
07 Jun 2017
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free